When: Successful retest of 10 EMA at ~$329 with RSI holding above 50 and volume declining on the test

Then: Add second third of intended 1.5% cap

When: Post-Q1 FY27 earnings print confirms stable or improving organic volume, operating margin, and cash conversion (not capex-depressed FCF)

Then: Add final third of intended 1.5% cap

HOLD

• 14% stop loss is not tight by institutional standards; tight stop would be 3.5% in the 325-322 zone based on ATR and 10 EMA support at 328.79
• FCF went from $3B to $5.1B but OCF only increased 27% from $7B to $8.9B; rest came from 38% capex drop ($6.2B to $3.8B)
• Normalized FCF yield is ~4% versus money market funds earning 5%, making current yield uncompelling
• $5.3B new debt issuance in FY26 while buybacks were cut from $3B to $800M signals potential capital allocation issues or cash quality concerns
• Stock consolidating between 325 and 339 after failing to break through 339.35 resistance near upper Bollinger Band at 342.69
• Volume dropped 25-50% from 1.5-2.5M shares to 1.10M on 08-25 close, indicating rally losing conviction
• MACD histogram essentially flat, expanding only from 4.07 to 4.32, showing non-accelerating momentum
• Current entry at $333.71 is only 3% below resistance zone of 342-344; risking chasing a failed breakout
• Q1 FY27 earnings in late September typically produce 5-7% moves in either direction; initiating before binary catalyst is unfavorable
• Preferred entry 1: Confirmed close above 342 on volume above 1.5M shares with stop at 50 SMA (319)
• Preferred entry 2: Pullback to 322-325 zone on declining volume with RSI holding above 50
• Current position: $333.71 with 0.5% portfolio allocation; stop at 322 would mean 14% loss versus 3.5% loss at better entry

→ vs aggressive: Seven basis points risk math is flawed; assumes execution at 285.73 on stop but gap-down scenario could blow through level entirely with ATR of $8 and beta of 1.36

→ vs aggressive: FCF inflection of 71% is one-time optical phenomenon from capex cuts, not earnings power; capex will normalize back to $5-6B next year when fleet replacement cycles resume

→ vs aggressive: Valuation at 18x trailing earnings with 6.5% FCF yield is not compelling when money market funds yield 5%; normalized FCF yield is closer to 4%

→ vs aggressive: Trend analysis is cycle-top pattern, not breakout; price failed at 339.35 and is digesting on declining volume, not coiled for explosive move

→ vs aggressive: MACD bullish cross shows flat histogram expansion (4.07 to 4.32), not accelerating momentum typical of sustained advance

→ vs aggressive: Amazon pivot narrative is unvalidated multi-year story with no quarter of clean data confirming higher-margin B2B and healthcare volume can replace consumer parcel

→ vs aggressive: Fed policy environment (86% probability of no cuts in 2026) affects shipper behavior, customer financing costs, and industrial freight demand, not just multiple expansion

→ vs aggressive: Consolidation opportunity is theoretically correct but uninvestable timing-wise; earnings impact may not show until 2027-2028

→ vs aggressive: Quiet retail footprint is lack of market validation, not contrarian opportunity; no options flow or broad investor interest signals market has not endorsed the trade

→ vs aggressive: Balance sheet strength making FedEx potential buyer could equally make it attractive acquisition target for foreign or strategic acquirer at discount to replacement cost

BUY

• FCF inflection is real: OCF improved from $7.0B to $8.9B (27% increase), not just a capex accounting trick
• Operating leverage is genuine: revenue +7.7%, EPS +10.3%, gross profit +8.7%
• Recommend tiered stop system: practical stop at 50 SMA (319.44, ~4.3% below current), hard stop at 200 SMA (285.73)
• Reduce initial tranche from 0.5% to 0.4% of portfolio to account for unresolved capital allocation questions
• Second tranche add-on requires either close above 342 on volume >1.5M shares OR successful retest of 10 EMA (328.79) with RSI >50
• The $5.3B new debt with buybacks cut from $3B to $800M (73% reduction) is a legitimate unresolved flag
• Declining volume in consolidation under resistance is ambiguous (common before breakout), not necessarily bearish distribution
• Earnings catalyst (Q1 FY27 late September, typically 5-7% move) should inform position sizing, not justify avoidance
• Total FDX cap stays at 1.5% but staging is slower than originally proposed

→ vs aggressive: 14% stop at 200 SMA conflates 'defined risk' with 'controlled risk'—a 14% stop on a 1.36 beta stock is just an obvious chart line, not tight risk management

→ vs aggressive: MACD positive but volume declining creates ambiguity about breakout probability—the 'seven basis points' framing is a math trick, not a risk framework

→ vs aggressive: 'Look through one-time items' doesn't address 73% buyback reduction as a sustained capital allocation decision, not an anomaly

→ vs conservative: 'Wait for proof before buying' is a logical trap—if you wait for confirmation, you're buying after the move, not at the inflection point that makes IBD buy points work

→ vs conservative: Macro argument is overweighted—FDX revenue accelerated to 7.7% in soft macro, evidence of share gain, and the IBD buy point is a company-specific catalyst, not a macro trade

→ vs conservative: 'Wait for pullback to 322-325' is directional market timing dressed as risk management with no edge—ATR is $8, pullback is one of two equally probable outcomes

→ vs conservative: Declining volume in tight consolidation under resistance is the most common pattern before breakout, not negligible 'bearish distribution'

→ vs conservative: Initiating at 333.71 while sitting 6 dollars below 08-13 high of 339.35 and 9 dollars below upper Bollinger Band at 342.69 contradicts the 'do not chase' guidance